APOA1 and bipolar disorder: Fitzet al. [49] further revealed through animal experiments that ApoA-I isassociated with β-amyloid clearance rates, suggesting that reduced HDLlevels may impair cognitive function in patients with bipolar disorder byaffecting cerebral β-amyloid clearance.